🇺🇸 FDA
Pipeline program

Photo-responsive nanozyme

2024-134-2

Unknown small_molecule active

Quick answer

Photo-responsive nanozyme for Radiation Dermatitis is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Radiation Dermatitis
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials